Clinical AI Knowing How to Use Tools Does Not Mean It Can Yet Make Safe Judgments

In medical settings, the risk of AI often lies not only in whether it can “answer,” but in whether it knows when to read images, when to check reports, when to calculate, and how to connect these steps into a traceable chain of judgment. A preprint posted to arXiv on June 10 proposed the MedCTA benchmark, attempting to move this question from general chat ability toward tool-use capabilities closer to clinical work.

MedCTA was released by teams related to the KAUST Image and Video Understanding Lab and is positioned as an evaluation benchmark for clinical tool agents. According to the paper abstract, project page, and official repository description, the dataset contains 107 multimodal tasks validated by clinical personnel, covering inputs such as radiology images, pathology slides, and clinical reports; each example includes not only a question and answer, but also a reference tool-use trajectory and final ground-truth answer.

The focus of these tasks is to have AI agents select and invoke tools when facing clinical questions. The five executable tools listed on the project page include OCR, image description, regional attribute description, Google Search, and a calculator. In other words, what the model is asked to do is not a single-turn Q&A, but to judge whether it needs to read text, describe a lesion region, look up external information, or complete numerical calculations, and then integrate the tool outputs into an answer.

The research team evaluated 18 models and analyzed 1,926 autonomous execution processes. The project page reports that the best autonomous result reached an accuracy of 31.54%, while the strongest open-source model reached 27.80%; but when models were provided with “gold-standard” tool routing, performance improved markedly. This gap points to a key limitation: many models may have the ability to interpret some information, yet do not stably know what tools to use, in what order to use them, and when to stop.

The official GitHub page further lists failure diagnoses, such as API error rates and insufficient tool calls; these figures come from the evaluation description released by the project and still need to be examined against the full paper and subsequent reproduction results. Still, the direction is already quite clear: in clinical AI agents, errors may arise not only from answer reasoning, but also from process management. A single missed use of OCR, an overlooked pathology region description, or excessive reliance on search could all cause subsequent reasoning to drift away from the patient data itself.

The Hugging Face dataset page shows that MedCTA is currently released under the Apache-2.0 license, with the train split containing 107 records. Fields include image, question, answer, tool name, tool chain, task category, trajectory, and structured ground-truth answer. In terms of scale, it is more like a finely annotated stress test than a large database that can directly represent all clinical scenarios; its value lies in breaking “whether tool use is reliable” into inspectable behaviors, rather than only comparing final answer accuracy.

For hospitals and regulators, this kind of benchmark is a reminder of a practical issue: if AI systems are to enter workflows for image interpretation, pathology assistance, or report aggregation, review cannot focus only on a model’s average score in closed tests. More important are how the system records each tool call, how it handles tool failures, how it prevents incorrect routing from being packaged as a fluent answer, and whether clinical personnel can intervene at critical points.

MedCTA itself remains a preprint and an open benchmark, and cannot be regarded as a validation conclusion for any clinical AI product. What it proposes is a more concrete measurement framework: if medical AI is to become an agentic system, it must prove not only that it can understand medical content, but also that it can remain stable in complex, cross-modal, tool-dependent workflows. That step is still far from clinical deployment, but it brings the discussion back from abstract capability to measurable safety.